UBS downgrades Novo Nordisk, cites 'rapidly deteriorating growth' in GLP-1 market
- Posted on August 5, 2025
- By CNBC
- 1 Views
UBS downgrades Novo Nordisk, cites 'rapidly deteriorating growth' in GLP-1 market
Novo Nordisk is losing market share despite its having a "comprehensive portfolio" compared to peers, the firm said.
